316 related articles for article (PubMed ID: 6967461)
21. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
22. Mycobacterium leprae-induced alterations in macrophage Fc receptor expression and monocyte-lymphocyte interaction in familial contacts of leprosy patients.
Mistry NF; Birdi TJ; Mahadevan PR; Antia NH
Scand J Immunol; 1985 Oct; 22(4):415-23. PubMed ID: 3906853
[TBL] [Abstract][Full Text] [Related]
23. Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria.
Convit J; Pinardi ME; RodrÃguez Ochoa G; Ulrich M; Avila JL; Goihman M
Clin Exp Immunol; 1974 Jun; 17(2):261-5. PubMed ID: 4619359
[TBL] [Abstract][Full Text] [Related]
24. M. leprae phagocytosis and its association with membrane changes in macrophages from leprosy patients.
Mistry NF; Birdi TJ; Antia NH
Parasite Immunol; 1986 Mar; 8(2):129-38. PubMed ID: 3517765
[TBL] [Abstract][Full Text] [Related]
25. Transfer factor as a probe of the immune defect in lepromatous leprosy.
Hastings RC
Int J Lepr Other Mycobact Dis; 1977; 45(3):281-91. PubMed ID: 336558
[No Abstract] [Full Text] [Related]
26. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
[TBL] [Abstract][Full Text] [Related]
27. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
28. Hydrogen peroxide and superoxide production by peripheral blood monocytes in leprosy.
Sharp AK; Banerjee DK
Clin Exp Immunol; 1985 Apr; 60(1):203-6. PubMed ID: 2988833
[TBL] [Abstract][Full Text] [Related]
29. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
[TBL] [Abstract][Full Text] [Related]
30. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
31. Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals.
Desai SD; Birdi TJ; Antia NH
Infect Immun; 1989 Apr; 57(4):1311-7. PubMed ID: 2494115
[TBL] [Abstract][Full Text] [Related]
32. The lepromatous macrophage defect as related to vaccine development in leprosy.
Skinsnes OK
Int J Lepr Other Mycobact Dis; 1976; 44(4):485-90. PubMed ID: 798730
[No Abstract] [Full Text] [Related]
33. Cellular immunity in patients with leprosy. Circulating T lymphocytes and their response to PHA in leprosy.
Kaklamanis E; Drouga M; Kouzoutzakoglou K; Karalis D; Trichopoulos D
Int J Lepr Other Mycobact Dis; 1977; 45(3):241-7. PubMed ID: 303622
[TBL] [Abstract][Full Text] [Related]
34. A study of cell-mediated immunity and histocompatibility antigens in leprosy patients in Iran.
Massoud A; Nikbin B; Nazari GR; Syadat NA; Ala F
Int J Lepr Other Mycobact Dis; 1978; 46(2):149-53. PubMed ID: 308050
[TBL] [Abstract][Full Text] [Related]
35. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients.
Chattree V; Khanna N; Rao DN
Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060
[TBL] [Abstract][Full Text] [Related]
36. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulation with corticosteroids and levamisole in leprosy as gauged by in vivo lepromin and in vitro CMI responses.
Kundu SK; Hazra SK; Chaudhuri SK; Nandy A
Indian J Lepr; 1985; 57(1):37-57. PubMed ID: 3839826
[TBL] [Abstract][Full Text] [Related]
38. [The genetic susceptibility to leprosy in humans].
Lagrange PH; Abel L
Acta Leprol; 1996; 10(1):11-27. PubMed ID: 8967289
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy.
Sieling PA; Abrams JS; Yamamura M; Salgame P; Bloom BR; Rea TH; Modlin RL
J Immunol; 1993 Jun; 150(12):5501-10. PubMed ID: 8515073
[TBL] [Abstract][Full Text] [Related]
40. Macrophage function in leprosy.
Parmaswaran M; Girdhar BK; Deo MG; Kandhari KC; Bhutani LK
Int J Lepr Other Mycobact Dis; 1976; 44(3):340-5. PubMed ID: 789263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
